tiprankstipranks
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market
JAZZ
Jazz Pharmaceuticals
RESEARCH TOOLSreports
Want to see JAZZ full AI Analyst Report?

Jazz Pharmaceuticals (JAZZ) Income Statement

1,879 Followers

Jazz Pharmaceuticals Income Statement

Last quarter (Q4 2025), Jazz Pharmaceuticals's total revenue was $1.20B, an increase of 10.09% from the same quarter last year. In Q4, Jazz Pharmaceuticals's net income was $203.45M. See Jazz Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.27B$ 4.07B$ 3.83B$ 3.66B$ 3.09B
Gross Profit
$ 3.76B$ 3.62B$ 3.40B$ 3.12B$ 2.65B
Operating Expenses
$ 3.54B$ 2.91B$ 2.82B$ 3.18B$ 2.48B
Depreciation and Amortization
$ 542.00M$ 660.07M$ 638.70M$ 629.47M$ 552.48M
EBITDA
$ 108.46M$ 1.52B$ 1.45B$ 1.47B$ 1.03B
Operating Income
$ 224.42M$ 716.63M$ 578.58M$ -65.53M$ 170.28M
Other Income/Expenses
$ -853.01M$ -247.94M$ -283.66M$ -317.18M$ -283.83M
Pretax Income
$ -628.59M$ 468.69M$ 294.92M$ -382.70M$ -113.55M
Net Income
$ -356.15M$ 560.12M$ 414.83M$ -224.06M$ -328.95M
Per Share Metrics
Basic EPS
$ -5.84$ 9.06$ 6.55$ -3.58$ -5.51
Diluted EPS
$ -5.84$ 8.65$ 6.10$ -3.58$ -5.51
Weighted Average Shares Outstanding
 60.98M 61.84M 63.29M 62.54M 59.69M
Weighted Average Shares Outstanding (Diluted)
 60.98M 66.01M 72.07M 62.54M 59.69M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History